| 000 | 01321 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513141909.0 | ||
| 264 | 0 | _c19980611 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0300-8126 | ||
| 024 | 7 |
_a10.1007/BF02767766 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatrai-Kovalskis, Y | |
| 245 | 0 | 0 |
_aPositive blood cultures for coagulase-negative staphylococci in neonates: does highly selective vancomycin usage affect outcome? _h[electronic resource] |
| 260 |
_bInfection _c |
||
| 300 |
_a85-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCoagulase _xbiosynthesis |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMorbidity |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xblood |
| 650 | 0 | 4 |
_aStaphylococcus _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
| 700 | 1 | _aGreenberg, D | |
| 700 | 1 | _aShinwell, E S | |
| 700 | 1 | _aFraser, D | |
| 700 | 1 | _aDagan, R | |
| 773 | 0 |
_tInfection _gvol. 26 _gno. 2 _gp. 85-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02767766 _zAvailable from publisher's website |
| 999 |
_c9528467 _d9528467 |
||